Cargando…
Association of Lupus Anticoagulant status with Disease Course in SARS-CoV-2 (COVID-19) Infection
Background: We investigated the importance of lupus anticoagulant (LA) in patients with SARS-CoV-2. Methods: Medical records of 41 SARS-CoV-2 infected patients were reviewed. Patients were classified into two groups according to the frequency of positive LA test results: “LA (−)” and “LA (+) ≥1” (LA...
Autores principales: | Woo, Suhyeon, Kim, Bohyun, Heo, Nam Hun, Kim, Min-sun, Yoon, Young Ahn, Choi, Young-Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523836/ https://www.ncbi.nlm.nih.gov/pubmed/36172745 http://dx.doi.org/10.1177/10760296221127276 |
Ejemplares similares
-
Prevalence and Impact of Lupus Anticoagulant in Patients Receiving Extracorporeal Membrane Oxygenation
por: Kornfehl, Andrea, et al.
Publicado: (2023) -
Routine Lupus Anticoagulant Sensitive aPTT Testing Can Prevent Unnecessary LA Testing
por: Smit, Bob, et al.
Publicado: (2023) -
How to Achieve Standardization? Diluted Russell Viper Venom Test for Lupus Anticoagulant Detection in a Chinese Female Population
por: Lu, Feng, et al.
Publicado: (2021) -
Standard-Intensity Versus Low-Intensity Anticoagulation with Warfarin
in Asian Patients with Atrial Fibrillation: A Multi-Center, Randomized
Controlled Trial
por: Cho, Jeong Gwan, et al.
Publicado: (2023) -
Management of Haemarthrosis in Patients On Oral Anticoagulants
por: Dalrymple, James, et al.
Publicado: (2022)